Retatrutide is a new pharmaceutical in the fight against obesity. This revolutionary drug, belonging to a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By activating these https://arunfcou768468.fireblogz.com/67547882/tirzepatide-a-promising-new-treatment-for-obesity